R
hodococcus equi is a zoonotic pathogen associated with pyogranulomatous pneumonia, mesenteric lymphadenitis, and development of abscesses in a variety of mammalian species, including humans.
1,2 The most common disease caused by the gram-positive intracellular bacterium is chronic suppurative bronchopneumonia in foals. 1, 3 Isolates of R equi in foals with rhodococcal pneumonia have an 85-to 90-kbp plasmid containing the gene (vapA) responsible for expression of the 15-to 17-kd virulence-associated protein antigen (VapA). [4] [5] [6] Virulent (vapA + ) and avirulent (vapA -) strains of R equi are normal inhabitants of soil [7] [8] [9] and are commonly found in the gastrointestinal tract or feces of healthy horses and other herbivores. 1, 10, 11 A 79-to 95-kbp plasmid containing the vapB gene, which codes for a 20-kd protein antigen (VapB) associated with strains of intermediate virulence, has been detected only in strains isolated from humans and pigs. [12] [13] [14] [15] Microbial culture of airway fluid obtained by neans of a tracheobronchial aspirate procedure is considered the gold standard in diagnosis of R equi pneumonia in foals, [16] [17] [18] despite the associated lag time and variability in sensitivity for recovering the organism from airway fluid samples. 19, 20 Results of microbial culture do not differentiate between virulent and avirulent R equi isolates. A rapid and cost-effective test with high sensitivity and specificity to simultaneously detect R equi and the vapA gene would be of diagnostic value.
Detection of R equi via traditional morphologic and biochemical tests and commercially available species identification systems is problematic because there is morphologic variability among isolates of the species and the specificity of these tests is limited. 1, [21] [22] [23] [24] These methods are unable to distinguish R equi isolates that are vapA + from isolates that are vapA -. The VapA antigen can be detected by use of a western immunoblot 4 assay or monoclonal antibody-based colony blot analysis. 25 Although the antibody-based colony blot analysis is less expensive and less technically demanding than the western immunoblot assay, a 24-hour incubation period is required and the test has been reported 11 to yield false-positive results. Restriction digestion coupled with Southern blot hybridization has been used to detect R equi 23 and vapA DNA 26 ; these techniques are time-consuming and technically complex and therefore not widely used. Recently, a colony blot hybridization assay was developed with products of a radiolabelled polymerase chain reaction (PCR) to detect R equi-specific ribosomal RNA (rRNA) and vapA gene sequences 27 ; although this method has advantages over other methods for screening large numbers of environmental or clinical samples, it requires the use of hazardous isotopes and is associated with a delay of > 24 hours for completion of tandem hybridization steps.
Numerous PCR-based techniques to identify R equi isolates exist, including amplification of speciesspecific regions of the 16S rRNA gene, 28-30 the cholesterol oxidase gene (choE), 31 and a certain unidentified genomic region. 32 in molecular microbiology, false-positive results are common because of the high sensitivity of the assay.
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False-negative results may also occur and are associated with enzyme inhibitors, DNA shearing, and insufficient quantity of template. 34 Consequently, mandatory implementation of internal amplification controls has been advocated for all diagnostic PCR assays to standardize the technique. 35 None of the methods based on PCR include internal controls, a shortcoming that limits their applicability as diagnostic tools. The purpose of the study reported here was to develop a highly specific and rapid multiplex PCR method to simultaneously detect R equi bacteria and differentiate vapA + from vapA -isolates.
Materials and Methods
Sample population-One hundred eighty-seven R equi isolates (Table 1 ) and 27 isolates of bacterial species genetically or morphologically similar to R equi were evaluated. Isolates of R equi (Appendix) were obtained from a variety of sources to assess specificity of the multiplex PCR assay. One hundred isolates were obtained via microbial culture of specimens from horses with clinical disease (ie, tracheobronchial fluid and lung tissues from foals with pneumonia [n = 78] and exudate from extrapulmonary infection sites in horses residing in Argentina [4] , Canada [7] , Ireland [7] , Israel [3] , Japan [12] , and the United States [67]). Fifty isolates of R equi were obtained via microbial culture of blood samples; extrapulmonary abscesses; and respiratory tract secretions, aspirates, or biopsy specimens from humans in Brazil (n = 2), Canada (1), France (1), Italy (3), Spain (1), and the United States (42) .
a Seven isolates were obtained from submissions to diagnostic laboratories b,c of specimens from nonequine species (ie, bovine [n = 1], canine [3] , caprine [1] , feline [1] , and porcine [1] specimens). Thirty isolates of R equi from soil on breeding farms where R equi pneumonia was or was not endemic were also evaluated (8 from Japan and 22 from the United States). The soil isolates were chosen nonrandomly from a repository of isolates screened for vapA 7, 36 to ensure inclusion of vapA + soil isolates and confirm reproducibility of our results. All other isolates were randomly chosen from a repository of > 600 R equi isolates collected between 1997 and 2004, none of which had been screened for vapA with the exception of a feline isolate (Table 1) . We included the R equi reference strains American Tissue Culture Collection (ATCC) 33701 (vapA + ) and ATCC 33703 (vapA -) as well as vapB + strains S1 and S3 d as positive controls in the PCR screening.
DNA isolation-Bacteria were grown on trypticase soy agar.
e The DNA from approximately half of the isolates was prepared by use of described 37 lysozyme extraction and phenol-chloroform-isoamyl alcohol purification methods after a 48-hour incubation period at 37 o C with rotation (10 revolutions/min) f in R equi minimal medium. 38 Concentration of DNA was determined spectrophotometrically, and working solutions (100 ng/µL) were prepared in 1X TE (10 mM TrisHCl and 1mM EDTA; pH, 8.0). For the remaining isolates, a modified alkaline lysis extraction method 39 was used: a single R equi colony was transferred into 300 µL of TENS solution (1X TE, 0.1N sodium hydroxide, and 0.5% SDS) with a sterile plastic loop. The solution was vortexed briefly, incubated at 21 o C for 10 minutes, and combined with 150 µL of 3N sodium acetate solution (pH, 5.2). The solution was vortexed and centrifuged at 14,000 X g for 2 minutes. In a new tube, 10 µL of polyacryl carrier g and 1 mL of isopropanol at 21 o C were added to the supernatant. The solution was inverted gently and centrifuged at 14,000 X g for 20 minutes. The DNA pellet was rinsed with ice-cold ethanol solution. After drying, the pellet was resuspended in 25 µL of 1X TE for use in the PCR assay.
Multiplex PCR assay-Three pairs of published primers were used in a single-tube multiplex PCR assay for simultaneous identification of vapA + strains of R equi, vapA -strains of R equi, and non-R equi bacterial isolates. Universal bacterial primers flanking a 311-bp fragment of the bacterial 16S rRNA gene were used as an internal control (27F 5'-AGAGTTTGATCMTGGCTCAG-3' and 338R 5'-GCTGCCTC-CCGTAGGAGT-3'). 40 A 959-bp fragment of the choE gene, located on the R equi chromosome, was used to differentiate R equi from non-R equi isolates (COXF 5'-GTCAACAACATC-GACCAGGCG-3' and COXR 5'CGAGCCGTCCACGACG-TACAG-3'). 31 A 564-bp product of the vapA gene, located on the R equi virulence-associated plasmid, was used to differentiate vapA + from vapA -isolates (VAPAF 5'-GACTCTTCACAA-GACGGT-3' and VAPAR 5'-TAGGCGTTGTGCCAGCTA-3'). o C for 10 minutes. All isolates were screened in duplicate in separate reactions to assess the reproducibility of the assay. Aliquots of DNA from R equi reference strain ATCC 33701 were diluted 10-fold and used to test sensitivity of the multiplex PCR method such that the final concentrations of template ranged from 100 to 0.001 ng/reaction.
Confirmation of results of multiplex PCR assay-
Isolates were additionally tested with choE and vapA primers in singleplex PCR assays to evaluate the specificity of the multiplex PCR assay. All R equi and non-R equi isolates were screened with the choE gene primer pair in a singleplex assay with 0.8µM each of COXF and COXR and 1.5mM MgCl 2 . Otherwise, the reaction mix was as described, and published thermal cycling protocols were followed. 31 All R equi isolates were also screened with the vapA gene primer pair in a singleplex assay following a published 7 protocol.
PCR screening for vapB-All R equi isolates were screened for the vapB gene by use of a modification of published 13 methods, including co-amplification of a 311-bp fragment of the bacterial 16S rRNA gene as an internal control. 40 For each reaction, 27F and 338R primers (0.4µM each) and VAPBH1 and VAPBH2
13 primers (0.8µM each) were used; the remaining reaction mix was as described. Thermal cycling parameters followed those previously published 13 with an increased number of total cycles from 30 to 35. All multiplex and singleplex PCR amplicons were separated and visualized on 1.2% agarose gels stained with ethidium bromide and electrophoresed for 60 to 90 minutes at 90 V.
Description of suspected non-R equi isolates-Two
1 However, results of repeated DNA extractions, multiple multiplex PCR assays, and singleplex PCR assay of the choE gene revealed that these isolates were not R equi. The isolates were screened by use of published 30, 32 species-specific PCR protocols for 2 genomic regions. Additionally, an amplicon of approximately 1,500 bp was obtained from these 2 isolates as well as R equi reference strain ATCC 33701 through the use of published 16S rRNA primers 31 (0.8µM each) and an annealing temperature of 54 o C; otherwise, assay conditions were as described. Resultant fragments were purified by use of a commercial kit.
k The 338R primer and a dye terminator sequencing kit l were used to generate partial 16S rRNA gene sequences; fragments were separated on a commercially available detection system m and manually inspected (GenBank accession No. AY758350-AY758352). A database search program 41 was used to identify highly similar sequences within the National Center for Biotechnology Information nucleotide database.
Results
Results of a typical multiplex PCR assay were recorded (Figure 1) . Of 187 R equi isolates screened, 58.3% (109/187) were vapA + and 3.7% (7/187) were vapB + ( Table 1) . None of the isolates were vapA + and vapB + . For each of the R equi isolates, results of duplicate multiplex assays were identical and comparable to the singleplex assays for choE and vapA, a finding that suggested high specificity and reproducibility of the 3 primer pairs in the multiplex PCR assay. Two R equi isolates (S1 and S3) that contained the vapB gene, which has 83.6% sequence similarity 42 with the vapA gene, were screened as a further test of the specificity of the assay. The S1 and S3 isolates yielded detectable products only from the universal 16S rRNA and choE primer pairs.
Amplification products for all 3 target regions were reliably detected with as little as 0.1 ng of template DNA from ATCC 33701 (Figure 1 ). An inverse relationship between the size of the target amplicon and amplification efficiency was observed; when 0.01 ng of template DNA was used, the largest fragment of 959 bp was not detected, whereas the smaller fragments were visible. Similarly, only the smallest amplicon was visible with 0.001 ng of template DNA. The mean ± SD quantity of DNA recovered by use of the alkaline lysis extraction method on a single isolated colony was 20.0 ± 12.7 ng/µL, representing a range of template DNA within that detectable by the multiplex PCR assay.
The choE primers in the singleplex PCR assay often amplified products smaller than 959 bp in non-R equi bacterial species. In the multiplex PCR assay, these primers were much less likely to amplify choE products in non-R equi spp, presumably because of competition of primers for target sites and imperfect base pairing of 1 or both primers to their respective targets. Rhodococcus fascians was the only non-R equi spp examined in which primers repeatedly amplified a choE fragment (approx 800 bp) by use of the vapA multiplex protocol ( Figure 1) ; in all other non-R equi spp, only the 27F-338R universal bacterial fragment was amplified. Variation in the concentrations of PCR components and thermal cycling conditions did not change this finding.
Neither of the 2 suspected non-R equi isolates yielded a detectable amplicon for the R equi-specific choE primer pair 31 in singleplex or multiplex assays (only the 16S rRNA internal control fragment was vis- ible). Both isolates failed to yield detectable amplicons with R equi-specific primers to 2 different genomic regions. 30, 32 For each isolate, a partial 16S rRNA gene sequence was generated and compared with publicly available sequences and with 16S rRNA sequences for R equi reference strains ATCC 6939 (accession X80603) and ATCC 33701 (accession AY758350; sequenced in the present study). The 16S rRNA nucleotide sequence from isolate 00-035 had the highest Basic Local Alignment Search Tool-N (BLASTN) scores and sequence similarity (98% to 99%) to species in genus Acinetobacter but only 83.0% (422 bp) and 80.6% (448 bp) nucleotide identity with R equi strains ATCC 6939 and ATCC 33701, respectively. Sequences obtained from non-R equi isolate H25 had the highest BLASTN scores and sequence similarity (98.3%; 593 bp) to multiple Nocardia veterans sequences. However, the 16S rRNA sequence in the H25 isolate was also highly similar to R equi ATCC 6939 and ATCC 33701, with nucleotide identities of 98.8% (564 bp) and 97.9% (482 bp), respectively.
Discussion
Polymerase chain reaction assays that target multiple genomic regions simultaneously are powerful tools for the detection of infectious agents. 43 In the present study, a multiplex PCR assay that targets 3 regions in the R equi genome permitted rapid, simultaneous detection of R equi and the virulence-associated vapA gene and was sensitive enough to detect 0.1 ng of target DNA. Cholesterol oxidase gene primers 31 consistently yielded an amplicon of < 959 bp by use of the singleplex and multiplex PCR assays in R fascians, a finding consistent with the close genetic relationship between R fascians and R equi 44, 45 and the high degree of conservation within the choE region. 46 Easily identified differences in the size of the choE fragment amplified in the multiplex PCR assay and the distinguishing morphologic characteristics 44 of the 2 bacterial species limit the likelihood of misidentifying isolates from these species. Although considerable chromosomal variability exists among isolates of R equi, 23, 29, 36 the assay detected R equi genetic material in samples obtained from widely varied sources. Results of analysis of vapB + and avirulent R equi strains indicated high specificity of the technique for amplification of the vapA gene region.
Extraction of DNA from a single bacterial colony can be completed within 1 hour by use of the methods described, yielding a sufficient quantity of template for approximately 25 reactions. Furthermore, the multiplex PCR assay described is cost-effective for routine diagnostic use by virtue of a small reaction volume (total, 25 µL) used, a short thermal profile (approx 2 hours), and low concentrations of agarose for amplicon separation (1.2%). The entire assay can be completed, from sampling bacterial colonies grown on agar plates to scoring PCR amplicons, in < 8 hours. The use of 16S rRNA universal bacterial primers as an internal PCR assay control allows direct detection of DNA extraction efficiency and confirmation of template presence to prevent erroneous interpretation of falsenegative results. 34, 35 The efficiency and reproducibility of this assay, combined with the ability to concurrently detect R equi and the vapA gene, are advantages over other PCR-based methods in which separate assays are required, internal amplification controls are not used, or inconsistent results are reported. 13, [26] [27] [28] [29] [30] [31] [32] 47 Although sequencing part or all of the 16S rRNA gene is common in genotypic identification of bacteria, this method has proven inadequate as a stand-alone diagnostic test in several instances. 48, 49 The cutoff value for sequence similarity among bacterial species is arbitrary; some isolates of different bacterial species may be more similar in the 16S rRNA sequence than variants of the same species. 49, 50 Therefore, in certain instances, multiple diagnostic tests are needed to accurately identify bacterial species. 51 In the study reported here, genotyping of PCR amplicons from 3 genomic regions in 2 bacterial isolates, 00-035 and H25, was used in addition to the 16S rRNA gene sequence analysis to confirm that the isolates were not R equi. Although the sequences in strain H25 shared a high degree of similarity to sequences in reference strains of R equi (97.9% to 98.8%), the amount of similarity was less than that reported between other validly described Rhodococcus spp (99.3%). 45 These results suggested that bacterial strain H25 was most likely an isolate of N veterans or a related Nocardia or Rhodococcus spp for which a published sequence for 16S rRNA is unavailable.
With the exception of the 30 soil isolates which were nonrandomly chosen from a large repository to include a number of vapA + isolates, the frequencies of detection of vapA + and vapB + strains of R equi can be compared with data from previous reports. Seventy-six of 78 (97.4%) pulmonary isolates collected from foals with suspected R equi pneumonia yielded positive results for the vapA gene, a value comparable to the range of 92% to 98% reported in earlier studies. 5, 7, 8, 52 In our study, the vapB gene was detected only in human and porcine isolates, a finding consistent with previous reports. 9, [12] [13] [14] [15] 53 None of the R equi isolates evaluated in our study had vapA and vapB genes, another finding that has been reported by others. 12, 13, 52 Results of previous investigations that evaluated R equi infections in humans indicated that 0% to 21% of strains were vapA +12,13,53,54 and 18% to 71% of strains were vapB + , 12,13,15,55 whereas we detected the genes in 14.0% and 12.0%, respectively, of the human R equi isolates screened. Results of the study reported here suggest that most R equi isolates from human patients do not contain the vapA or vapB virulence genes. Of the nonequine veterinary R equi isolates screened in our study, only 1 vapA + isolate was detected (from a wound in a cat), a finding consistent with that of a previous report. 53 It is possible that other virulence genes on the R equi chromosome or extrachromosomal plasmid are responsible for virulence in mammalian species other than horses and pigs. It is also possible that the ability of R equi to infect nonequine or nonporcine mammals is not associated with specific virulence genes but rather is dependent on host immunity and exposure to the opportunistic pathogen.
Use of a direct PCR assay on isolates obtained from tracheobronchial fluid has been proposed 47 as an alternative to microbial culture of the fluid for the diagnosis of R equi pneumonia. [16] [17] [18] In an earlier study, 16 low sensitivity of detection of vapA sequences in tracheobronchial fluid, compared with direct culture, was reported. Microbial culture of R equi from tracheobronchial fluid will likely remain necessary in the diagnosis of pneumonia in foals and in guiding treatment of disease via susceptibility testing. Because detection of R equi by use of microbial culture and biochemical testing can be inaccurate and time-consuming, 1,21-24 the multiplex PCR assay may be a useful diagnostic tool. The multiplex PCR assay appeared to provide an efficient and accurate method for epidemiologic screening of soil and tissue or fluid samples from nonequine mammalian and environmental sources for R equi in which the prevalence of vapA + strains of the bacterium is generally low. GeneAmp PCR System 9700, Applied Biosystems, Foster City, Calif. k. Gel extraction purification kit, QIAGEN Inc, Valencia, Calif. l.
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